Topics

Tris Pharma, Inc. Company Profile

09:38 EST 27th January 2020 | BioPortfolio


News Articles [924 Associated News Articles listed on BioPortfolio]

Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen

Monmouth Junction, NJ, Tris Pharma, Inc. is expanding the scope of its November 2018 recall by adding three (3) additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the retai...

Intellipharmaceutics International Inc.: Intellipharmaceutics Signs a Second Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

TORONTO, ON / ACCESSWIRE / September 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing ...

Intellipharmaceutics International Inc.: Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

TORONTO, ON / ACCESSWIRE / August 15, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in t...

Intellipharmaceutics International Inc.: Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER

TORONTO, ON / ACCESSWIRE / November 25, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

Mylan and Upjohn merger will create a new entity: Viatris

The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has been revealed. The new entity will be known as Viatris, a name derived from Latin which...

Intellipharmaceutics Signs a Second Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

TORONTO, ON / ACCESSWIRE / September 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company speciali...

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER

TORONTO, ON / ACCESSWIRE / November 25, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical compa...

LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma

BALLERUP, Denmark–(BUSINESS WIRE)–Today, LEO Pharma announced the sale of 10 products to Karo Pharma AB for 90 MEUR. The divested portfolio is non-core to LEO Pharma’s business, and was ...

Drugs and Medications [60 Associated Drugs and Medications listed on BioPortfolio]

Dexmethylphenidate hydrochloride [tris pharma inc]

Dexmethylphenidate Hydrochloride Tablets CII Rx only

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]

NA

PubMed Articles [124 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

III. THE ROLE OF THE RESEARCH ETHICS COMMITTEES IN THE REGULATION OF PHARMA-SPONSORED STUDIES.

Participants of Pharma-sponsored research are exposed to risks, benefits, and uncertainties that do not occur in other forms of clinical studies. Ethics committees represent the subjects' first line o...

Tris-Co(II)-HO System-Mediated Durative Hydroxyl Radical Generation for Efficient Anionic Azo Dye Degradation by Integrating Electrostatic Attraction.

The development of simple Fenton/Fenton-like systems with durative hydroxyl radical (OH) generation characteristics is significant to rapid organic pollutant degradation and cost-effective water treat...

Bis(2-pyridyl) and Tris(2-pyridyl) Compounds of Gallium and Indium a Redox-Transmetalation Route.

Reactions of the tris(2-pyridyl)lead(II) compound [LiPb(2-py)] () with trialkyl compounds of the group 13 elements gallium and indium resulted in the bis(2-pyridyl) and tris(2-pyridyl) gallate complex...

The Art of Virtualizing Pharma R&D.

Clinical Trials [101 Associated Clinical Trials listed on BioPortfolio]

Study of Oral Palifosfamide Tris in Solid Tumors

The study of maximum tolerated dose and safety of oral palifosfamide tris capsules in advanced, refractory, solid tumors

Comparison of Pain After Uterine Artery Embolization

The primary purpose of this study is to compare pain after uterine artery embolization using non-spherical polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with sy...

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver

The primary aim of this trial is to estimate the duration of hepatic progression-free survival (HPFS) in participants treated with bland embolization (BE), transcatheter arterial Lipiodol ...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Companies [845 Associated Companies listed on BioPortfolio]

Tris Pharma

Tris Pharma is a product-focused, specialty pharmaceutical company engaged in the research and development of innovative drug delivery technologies. Through its OralXR+ platform, Tris has pioneered th...

Tris Pharma, Inc

Tris Pharma is a privately owned specialty pharmaceutical company engaged in the research and development of drug delivery technologies. We develop the most difficult-to-formulate products by leveragi...

Tris Pharma, Inc.

Intergrated Biologics

Zwitterionic Biological Response Modifiers.(examples:HEPES,MES,MOPS,Tris)US Patent 6,071,919

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "Tris Pharma, Inc." on BioPortfolio

We have published hundreds of Tris Pharma, Inc. news stories on BioPortfolio along with dozens of Tris Pharma, Inc. Clinical Trials and PubMed Articles about Tris Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tris Pharma, Inc. Companies in our database. You can also find out about relevant Tris Pharma, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record